The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

The Federal Trade Commission also reported the “Big ... Her company, which owns Aetna, the pharmacy benefits manager operation CVS Caremark and several doctors’ clinic chains, reported ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

UnitedHealthcare's legal drug dealing arm is, according to the government, massively marking up the cost of life-saving ...

In late December, President-elect Donald Trump put pharmacy benefit managers ... Warren and activist regulators at Joe Biden’s Federal Trade Commission, which dropped a report just days before ...

The Federal Trade Commission has released its second report digging into how the business practices of pharmacy benefit managers ... The Pharmaceutical Care Management Association, the largest ...

A new Federal Trade Commission (FTC) report found that the three largest Pharmacy Benefit Managers (PBMs ... Pharmaceutical Care Management Association Vice President of Public Affairs Greg ...

The Pharmaceutical Care Management Association, which represents PBM's, called the FTC report baseless and "without substantiating evidence." ...

Agency commissioners voted unanimously on Tuesday to publish the report, which makes a similar attack on the drug middlemen ...

were down around 1% after the Federal Trade Commission (FTC) accused their pharmacy benefit manager units of imposing significant price markups on specialty generic drugs, according to a new ...